74 related articles for article (PubMed ID: 16271085)
1. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
2. Tumor-matrix interaction induces phenotypic switching in liver cancer cells.
Yuan RH; Hsu CL; Jhuang YL; Liu YR; Hsieh TH; Jeng YM
Hepatol Int; 2022 Jun; 16(3):562-576. PubMed ID: 35525880
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Jiang S; Lu H; Pan Y; Yang A; Aikemu A; Li H; Hao R; Huang Q; Qi X; Tao Z; Wu Y; Quan C; Zhou G; Lu Y
Cancer Lett; 2024 Apr; 588():216799. PubMed ID: 38479553
[TBL] [Abstract][Full Text] [Related]
4. Alternative lengthening of telomeres in primary hepatic neoplasms.
Yasir S; Thompson S; Chen ZE; Knudson R; Knutson D; Kloft-Nelson S; Graham RP; Jain D; Simon SM; Wu TT; Torbenson M
Hum Pathol; 2023 Jan; 131():79-86. PubMed ID: 36370823
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC.
Chen S; Liao C; Hu H; Liao J; Chen Z; Li S; Zeng X; Peng B; Shen S; Li D; Li S; Lai J; Peng S; Xie Y; Kuang M
Hepatology; 2024 Apr; 79(4):780-797. PubMed ID: 37725755
[TBL] [Abstract][Full Text] [Related]
6. CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
Sciarra A; Monteiro I; Ménétrier-Caux C; Caux C; Gilbert B; Halkic N; La Rosa S; Romero P; Sempoux C; de Leval L
Cancer Immunol Immunother; 2019 Mar; 68(3):467-478. PubMed ID: 30607549
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes of Incidental Liver Malignancies in Simultaneous Liver-Kidney Transplant Recipients.
Rodríguez-Espinosa D; Morantes L; García J; Broseta JJ; Cuadrado-Payán E; Colmenero J; Torregrosa JV; Diekmann F; Esforzado N
Transplant Proc; 2024 Mar; 56(2):330-334. PubMed ID: 38350821
[TBL] [Abstract][Full Text] [Related]
8. Single-cell and spatial architecture of primary liver cancer.
Zhou PY; Zhou C; Gan W; Tang Z; Sun BY; Huang JL; Liu G; Liu WR; Tian MX; Jiang XF; Wang H; Tao CY; Fang Y; Qu WF; Huang R; Zhu GQ; Huang C; Fu XT; Ding ZB; Gao Q; Zhou J; Shi YH; Yi Y; Fan J; Qiu SJ
Commun Biol; 2023 Nov; 6(1):1181. PubMed ID: 37985711
[TBL] [Abstract][Full Text] [Related]
9. Preliminary study of some of the main intratumor stroma components in gastric carcinomas.
Liţescu M; Marincaş AM; Mitroi G; Pleşea IE; Strâmbu VDE; Grigorean VT; Prunoiu VM; Pleşea RM; Gherghiceanu F
Rom J Morphol Embryol; 2023; 64(3):363-378. PubMed ID: 37867354
[TBL] [Abstract][Full Text] [Related]
10. Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features.
Murtha-Lemekhova A; Fuchs J; Schulz E; Sterkenburg AS; Mayer P; Pfeiffenberger J; Hoffmann K
J Hepatocell Carcinoma; 2021; 8():1269-1279. PubMed ID: 34712626
[TBL] [Abstract][Full Text] [Related]
11. Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers.
Hendaoui I; Lahmar A; Campo L; Mebarki S; Bichet S; Hess D; Degen M; Kchir N; Charrada-Ben Farhat L; Hefaiedh R; Ruiz C; Terracciano LM; Tucker RP; Hendaoui L; Chiquet-Ehrismann R
Front Immunol; 2020; 11():630139. PubMed ID: 33692777
[TBL] [Abstract][Full Text] [Related]
12. CT-Guided Percutaneous Microwave Ablation of Sclerosing Hepatic Carcinoma.
Song H; Ding H; Zhu C
Can J Gastroenterol Hepatol; 2020; 2020():8881978. PubMed ID: 32733821
[TBL] [Abstract][Full Text] [Related]
13. Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.
Yang YSH; Chang HW; Lin IH; Chien LN; Wu MJ; Liu YR; Chu PG; Xie G; Dong F; Jia W; Chang VHS; Yen Y
Sci Rep; 2020 Jan; 10(1):866. PubMed ID: 31964941
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological characterization of small hepatocellular carcinoma with fibrous stroma.
Yagi T; Nakanuma Y; Sato Y; Nitta T; Sasaki M; Gabata T; Harada K
Int J Clin Exp Pathol; 2018; 11(10):4806-4816. PubMed ID: 31949555
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist.
Quaglia A
J Hepatocell Carcinoma; 2018; 5():99-108. PubMed ID: 30519546
[TBL] [Abstract][Full Text] [Related]
16. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
Choi SY; Kim YK; Min JH; Kang TW; Jeong WK; Ahn S; Won H
Eur Radiol; 2018 Jun; 28(6):2549-2560. PubMed ID: 29335868
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
18. Tenascin-C expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients and the inflammatory cytokine TNF-α-induced TNC expression promotes migration in HCC cells.
Nong Y; Wu D; Lin Y; Zhang Y; Bai L; Tang H
Am J Cancer Res; 2015; 5(2):782-91. PubMed ID: 25973315
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.
Joo I; Kim H; Lee JM
Korean J Radiol; 2015; 16(1):50-68. PubMed ID: 25598674
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
